翻新 MRI 系統市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024 年，全球翻新 MRI 系統市場估值達 8.245 億美元，預計到 2034 年將以 5.1% 的複合年成長率成長，達到 13.5 億美元。翻新 MRI 系統持續受到青睞，因為它們為資金有限的醫療服務提供者提供了實用且經濟高效的解決方案。由於全新的 MRI 機器價格在 100 萬美元至 300 萬美元之間，許多中小型醫療機構往往無法負擔。相較之下，翻新機器提供了符合成像性能標準的可靠替代方案，使其成為資金不足的醫療環境中改善診斷途徑的重要資源。對公平取得醫學影像服務的需求日益成長，尤其是在經濟受限地區，這是推動這些系統需求的核心因素之一。

翻新的MRI系統並非簡單的回收產品；它們經過精心檢修，以滿足原始規格並確保高品質的成像效果。其價格實惠，使醫療機構能夠在不超出緊張預算的情況下擴展診斷服務。此外，無需等待新機器通常伴隨的漫長交付週期，即可提供必要的影像服務，這也增加了它們的吸引力。隨著全球醫療保健系統面臨患者人數不斷成長和慢性病發病率不斷上升的問題，對可靠、便利且價格合理的影像解決方案的需求變得至關重要。翻新的MRI系統有效地填補了這一空白，幫助醫療機構在控制營運成本的同時保持照護水準。它們的使用也有助於縮小資源豐富地區和服務欠缺地區之間醫療技術可用性的差距，從而支持實現全球健康公平的長期目標。

2024年，封閉式MRI系統佔據了翻新MRI系統市場的絕大部分佔有率，佔全球收入的66.2%。封閉式系統憑藉其卓越的影像清晰度和先進的診斷能力，仍然是許多醫療機構的首選。這些系統支援高磁場強度，使其能夠檢測微小異常，並為複雜的臨床評估提供精確的成像。醫療機構選擇翻新的封閉式MRI設備是為了獲得高品質的診斷，而無需承擔購買新型號的成本負擔。預計這些系統的持續成長將在整個預測期內保持主導地位。

根據磁場強度，中場磁振造影系統類別在2024年佔據市場領先地位，估值達4.554億美元。中場磁振造影系統（最常見的是1.5T）因其在各種診斷程序中的多功能性而廣受認可。醫療保健提供者青睞這些系統，因為它們能夠提供高解析度影像，同時保持成本效益。 1.5T機器在全球範圍內的廣泛應用為翻新設備創造了一個強勁的二級市場，使醫療機構能夠以經濟實惠的方式在其網路中提供全面的影像服務。這有助於確保患者能夠獲得必要的診斷服務，而無需醫療機構在品質或預算方面做出妥協。

在終端用戶中，醫院在2024年佔據了最大的市場佔有率，達到42.7%。預算限制通常會阻礙許多醫院，尤其是規模較小或偏遠地區的醫院，購買新的MRI系統。翻新設備提供了一個可行的解決方案，使這些機構能夠在預算範圍內升級或擴展成像能力。與新系統相比，醫院不僅受益於較低的前期成本，還受益於更短的交付時間。這使得醫院能夠更快地更換過時或無法正常運作的設備，並有助於滿足患者日益成長的診斷服務需求。隨著全球慢性病和複雜疾病負擔的增加，醫院越來越依賴可靠的MRI系統來提供及時且準確的照護。

從地區來看，北美是2024年領先的市場，價值達3.686億美元。預計到2034年，該地區將以5%的複合年成長率穩定成長，這得益於不斷成長的醫療保健需求和成本敏感型購買行為。在該地區，光是美國在2024年的市場規模就達3.326億美元，預計到2034年將達到5.382億美元。面對高昂的醫療支出和資金限制，許多醫院和診斷中心正在將翻新的MRI系統視為策略性投資。這些系統使醫療保健提供者能夠在保留診斷能力的同時更有效地管理預算。

翻新MRI系統市場競爭激烈，既有國際巨頭，也有本土企業。頂級公司佔據約65%的市場佔有率，提供客製化的高效能系統，以滿足醫療保健提供者不斷變化的需求。隨著需求的成長和技術的進步，製造商正在調整其定價和產品策略，以在全球多元化市場提供價格合理、合規且耐用的MRI系統。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
  • 供應商格局
  • 每個階段的增值
  • 影響價值鏈的因素
• 產業衝擊力
  • 成長動力
    • 對經濟高效的成像解決方案的需求不斷成長
    • 慢性病盛行率不斷上升
    • 擴大發展中地區的診斷中心
    • 更加重視醫療保健的永續性
  • 產業陷阱與挑戰
    • 對產品品質和性能的擔憂
    • 缺乏標準化法規
  • 市場機會
• 成長潛力分析
• 監管格局
• 技術和創新格局
  • 當前的技術趨勢
  • 新興技術
• 價格趨勢
  • 按地區
  • 按產品
• 報銷場景
  • 報銷政策對市場成長的影響
• 未來市場趨勢
• 消費者行為分析
• 專利分析
• 波特的分析
• PESTEL分析

第4章：競爭格局

• 介紹
• 競爭市佔率分析
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 關鍵進展
  • 併購
  • 夥伴關係和合作
  • 新產品發布
  • 擴張計劃

第5章：市場估計與預測：按系統類型，2021 - 2034 年

• 主要趨勢
• 封閉式MRI系統
• 開放式MRI系統

第6章：市場估計與預測：按場強，2021 - 2034 年

• 主要趨勢
• 低場MRI系統
• 中場MRI系統
• 高場MRI系統

第7章：市場估計與預測：依最終用途，2021 - 2034 年

• 主要趨勢
• 醫院
• 門診手術中心
• 診斷影像中心
• 研究機構和學術中心

第8章：市場估計與預測：按地區，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• Aegys
• Amber Diagnostics
• Avante Health Solutions
• Block Imaging
• Canon Medical Systems
• DirectMed Imaging
• Fujifilm Healthcare
• GE HealthCare
• Integrity Medical Systems
• Koninklijke Philips
• LBN Medical
• MedScanner
• Providian Medical
• Siemens Healthineers
• SOMA Technology

The Global Refurbished MRI Systems Market reached a valuation of USD 824.5 million in 2024 and is estimated to grow at a CAGR of 5.1% to reach USD 1.35 billion by 2034. Refurbished MRI systems continue to gain traction as they offer a practical, cost-effective solution to healthcare providers with limited capital. As brand-new MRI machines can cost anywhere between USD 1 million and USD 3 million, they often remain financially inaccessible for many small and mid-sized healthcare organizations. In contrast, refurbished machines provide a reliable alternative that meets imaging performance standards, making them an essential resource for improving diagnostic access in underfunded healthcare environments. The increasing demand for equitable access to medical imaging, especially in economically constrained regions, is one of the core factors driving the demand for these systems.

Refurbished MRI systems are not simply recycled products; they are carefully overhauled to meet original specifications and ensure quality imaging outcomes. Their affordability allows facilities to expand diagnostic services without exceeding tight budgets. Additionally, the ability to deliver essential imaging services without waiting for the long lead times often associated with new machines adds to their appeal. As global healthcare systems face growing patient populations and increasing incidences of chronic illness, the need for dependable, accessible, and affordable imaging solutions has become critical. Refurbished MRI systems fill this gap effectively, helping providers maintain care standards while managing operational costs. Their use also helps reduce the disparity in medical technology availability between well-resourced and underserved regions, supporting the long-term goal of global health equity.

In 2024, the closed MRI systems segment held the majority of the refurbished MRI systems market, accounting for 66.2% of global revenue. Closed systems remain the preferred option for many facilities due to their superior image clarity and advanced diagnostic capability. These systems support high magnetic field strengths, allowing them to detect small abnormalities and provide precise imaging for complex clinical evaluations. Facilities opt for refurbished closed MRI units to access high-quality diagnostics without the cost burden of purchasing new models. The continued preference for these systems is expected to sustain their dominance through the forecast period.

Based on magnetic field strength, the mid-field MRI systems category led the market in 2024 with a valuation of USD 455.4 million. Mid-field MRI systems-most commonly 1.5T-are widely recognized for their versatility across a range of diagnostic procedures. Healthcare providers favor these systems because they deliver high-resolution images while maintaining cost-efficiency. The widespread adoption of 1.5T machines across the globe has created a robust secondary market for refurbished units, giving providers an affordable means of offering comprehensive imaging services across their networks. This helps ensure that patients can access essential diagnostics without facilities needing to compromise on quality or budget.

Among end users, hospitals represented the largest market share in 2024 at 42.7%. Budgetary constraints often prevent many hospitals, especially smaller or rural facilities, from acquiring new MRI systems. Refurbished units offer a viable solution, enabling these institutions to upgrade or expand imaging capabilities within financial limits. Hospitals benefit not only from the lower upfront costs but also from shorter delivery timelines compared to new systems. This allows quicker replacement of outdated or non-functional units and helps meet growing patient demands for diagnostic services. As the global burden of chronic and complex conditions rises, hospitals increasingly rely on dependable MRI systems to deliver timely and accurate care.

Regionally, North America was the leading market in 2024, valued at USD 368.6 million. The region is forecast to grow at a steady pace of 5% CAGR through 2034, driven by rising healthcare needs and cost-sensitive purchasing behaviors. Within this region, the United States alone accounted for USD 332.6 million in 2024 and is expected to reach USD 538.2 million by 2034. Faced with high healthcare expenditures and capital limitations, many hospitals and diagnostic centers are turning to refurbished MRI systems as a strategic investment. These systems allow healthcare providers to preserve diagnostic capabilities while managing budgets more effectively.

The refurbished MRI systems market is competitive, featuring both international giants and local players. Collectively, top companies hold approximately 65% of the market share, offering tailored, high-performance systems to meet the evolving needs of healthcare providers. With increasing demand and technological advancements, manufacturers are adapting their pricing and product strategies to deliver affordable, compliant, and durable MRI systems across diverse global markets.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product
  • 2.2.3 Application
  • 2.2.4 End Use
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Value addition at each stage
  • 3.1.3 Factor affecting the value chain
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising demand for cost-effective imaging solutions
    • 3.2.1.2 Growing prevalence of chronic diseases
    • 3.2.1.3 Expansion of diagnostic centers in developing regions
    • 3.2.1.4 Increased emphasis on sustainability in healthcare
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Concerns over product quality and performance
    • 3.2.2.2 Lack of standardized regulations
  • 3.2.3 Market opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Price trends
  • 3.6.1 By region
  • 3.6.2 By product
• 3.7 Reimbursement scenario
  • 3.7.1 Impact of reimbursement policies on market growth
• 3.8 Future market trends
• 3.9 Consumer behaviour analysis
• 3.10 Patent analysis
• 3.11 Porter's analysis
• 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Competitive market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New Product Launches
  • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By System Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Closed MRI systems
• 5.3 Open MRI systems

Chapter 6 Market Estimates and Forecast, By Field Strength, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Low-field MRI systems
• 6.3 Mid-field MRI systems
• 6.4 High-field MRI systems

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Diagnostic imaging centers
• 7.5 Research institutes and academic centers

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Mexico
  • 8.5.2 Brazil
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Aegys
• 9.2 Amber Diagnostics
• 9.3 Avante Health Solutions
• 9.4 Block Imaging
• 9.5 Canon Medical Systems
• 9.6 DirectMed Imaging
• 9.7 Fujifilm Healthcare
• 9.8 GE HealthCare
• 9.9 Integrity Medical Systems
• 9.10 Koninklijke Philips
• 9.11 LBN Medical
• 9.12 MedScanner
• 9.13 Providian Medical
• 9.14 Siemens Healthineers
• 9.15 SOMA Technology